Synthesis, in vitro and in vivo characterization of two novel 68Ga-labelled 5-nitroimidazole derivatives as potential agents for imaging hypoxia

RADIOFARMACIA

HIPOXIA

BIBLIOGRAFIA NACIONAL QUIMICA

2013

Introduction: Hypoxia imaging is an important field in radiopharmaceutical research since hypoxic cells are very resistant to radiation treatment and diffusional limitations restrict the efficacy of chemotherapy. Gallium-68 is a widely used radionuclide for positron emission tomography (PET) due to the availability of the 68Ge/68Ga-generator. With the aim to develop new potential [68Ga]-radiopharmaceuticals for imaging hypoxia, we have synthesized and evaluated two novel 68Ga-labelled 5-nitroimidazole derivatives. Methods: Two 5-nitroimidazole derivatives, 10-[2-(2-methyl-5-nitro-1 H-imidazole-1-yl)ethylaminocarbonylmethyl]- 1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid (Nit1) and 10-{[N-methyl-1-[1-(2-(2-methyl- 5-nitro-1 H-imidazole-1-yl)ethyl)-1 H-1,2,3-triazole-4-yl] methylaminocarbonylmethyl}-1,4,7,10- tetraazacyclododecane-1,4,7-triacetic acid (Nit2) were synthesized. Preparation of [68Ga]complexes [68Ga]- Nit1 and [68Ga]-Nit2 was performed at pH 4.5 and 95 °C during 15 minutes and radiochemical purity (RP) was evaluated by reverse phase HPLC. Stability, lipophilicity and plasma protein binding were studied. Biological behaviour in HCT-15 cells both in normoxia and hypoxia has been assessed. Biodistribution in animals bearing induced 3LL Lewis murine lung carcinoma was studied. Comparison with [18F]FMISO is also presented. Results: Nit1 and Nit2 have been successfully synthesized. Labelling in high radiochemical purity was achieved for both ligands. Complexes are stable in labellingmilieu for at least four hours and in human plasma or in the presence of an excess of DTPA for at least two hours. Both compounds showed high uptake in hypoxic cells in vitro and a very favourable biodistribution profile in mice bearing induced tumours. Results are comparable to those obtained for [18F]FMISO. Conclusions: Selective uptake and retention in tumour together with favourable tumour/muscle ratio make these compounds promising candidates for further evaluation as potential hypoxia imaging agents.

Nuclear Medicine and Biology v. 40, 2013.-- p.273-279

Elsevier

2013

Información sobre Derechos de Autor

(Por favor lea este aviso antes de abrir los documentos u objetos)

La legislación uruguaya protege el derecho de autor sobre toda creación literaria, científica o artística, tanto en lo que tiene que ver con sus derechos morales, como en lo referente a los derechos patrimoniales con sujeción a lo establecido por el derecho común y las siguientes leyes

(LEY 9.739 DE 17 DE DICIEMBRE DE 1937 SOBRE PROPIEDAD LITERARIA Y ARTISTICA CON LAS MODIFICACIONES INTRODUCIDAS POR LA LEY DE DERECHO DE AUTOR Y DERECHOS CONEXOS No. 17.616 DE 10 DE ENERO DE 2003, LEY 17.805 DE 26 DE AGOSTO DE 2004, LEY 18.046 DE 24 DE OCTUBRE DE 2006 LEY 18.046 DE 24 DE OCTUBRE DE 2006)

ADVERTENCIA - La consulta de este documento queda condicionada a la aceptación de las siguientes condiciones de uso: Este documento es únicamente para usos privados enmarcados en actividades de investigación y docencia. No se autoriza su reproducción con fines de lucro. Esta reserva de derechos afecta tanto los datos del documento como a sus contenidos. En la utilización o cita de partes debe indicarse el nombre de la persona autora.

 

PDF

Inglés

Artículo

http://dx.doi.org/10.1016/j.nucmedbio.2012.11.003